| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |